Intelligent infusion pump with variable pulse interval and control method thereof
The intelligent infusion pump control system with variable pulse interval solves the problem that existing pulse infusion pumps cannot deliver in time during the pre-pulse lock-in period, enabling flexible individualized analgesia and reducing analgesia waiting time.
Patent Information
- Application Number
- CN202411544112.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-31
- Publication Date
- 2024-11-29
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Existing pulse infusion pumps cannot deliver infusions in a timely manner when pain is required during the pre-pulse lock-in period, resulting in increased analgesia waiting time and failing to meet individualized analgesia needs.
The system employs an intelligent infusion pump with variable pulse intervals. Infusion parameters such as pulse interval and pre-pulse latency are set through the control system to achieve pre-pulse locking. The pulse cycle is adjusted in real time according to the self-controlled activation signal to meet individualized analgesia needs.
It reduces the waiting time for analgesia, improves the flexibility of infusion and the individualized analgesic effect, and meets individualized analgesia needs.
Smart Images

Figure CN119034051A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of medical devices and intelligent infusion control, and more specifically to an intelligent infusion pump with variable pulse interval and a control method thereof. Background Art
[0002] The pulse electronic infusion pump is a micro-infusion device, which generally includes a pump body, a liquid storage device and an infusion pipeline, and also includes an automatic liquid feeding device. When used, compared with a single automatic infusion, the pulse infusion has a faster pumping speed. In the case of intraspinal or continuous peripheral nerve block, at the same dose, the pulse infusion has a wider analgesic range and better analgesic effect. The existing pulse infusion mode is a constant interval, which automatically performs a pulse infusion volume every fixed period. When additional analgesia is required, an additional single infusion can be performed by pressing the automatic drug administration button. In addition, in the existing pulse mode, there is a pre-pulse lock, and there will be a pre-pulse automatic control invalid period before the next pulse arrives. The purpose is to avoid short-term excessive infusion caused by too close intervals between automatic infusion and pulse infusion. If there is no effective automatic infusion, after entering the pre-pulse lock, pain cannot be infused, which will increase the waiting time for insufficient analgesia. Summary of the invention
[0003] In view of the shortcomings of the prior art, the present invention provides an intelligent infusion pump with variable pulse interval and a control method thereof, which has no pre-pulse lock time and can perform early pulse infusion when needed, thereby reducing waiting time and meeting individualized analgesia needs.
[0004] To achieve the above-mentioned purpose, the present invention provides the following technical solutions: an intelligent infusion pump with variable pulse interval, comprising a pump body, a liquid storage device, an infusion pipeline and a control system, etc.; wherein the control system can set infusion parameters such as the total infusion amount, the first amount, the first amount lock time, the pulse amount, the pulse interval, the post-pulse lock time, the pre-pulse latent time, the limit amount and the continuous infusion amount.
[0005] After setting the parameters, the first volume infusion and the first volume lock time will be entered. After the first volume lock time is over, the first pulse infusion will be automatically entered. After the first pulse infusion is completed, the post-pulse lock time will be entered. After the post-pulse lock time is over, the pre-pulse latent time will be entered. After the pre-pulse latent time is over, the next pulse infusion will be carried out, that is: post-pulse lock time + pre-pulse latent time = pulse interval time. A pulse cycle is from the appearance of a pulse to the arrival of the next pulse. If the self-control activation signal appears during the post-pulse lock time, it is invalid self-control; if the self-control signal is activated during the pre-pulse latent time, the pulse infusion will be carried out in advance.
[0006] Furthermore, the control system can also set the change size, upper limit and lower limit of each pre-pulse latency. The conditions for automatically increasing and decreasing the pre-pulse latency are: pulse advance occurs in N consecutive pulse cycles and pulse advance does not occur in M consecutive pulse cycles.
[0007] For example, if the auto-activation signal appears during the pre-pulse latency of two consecutive pulse cycles, resulting in two consecutive premature pulse infusions, the pre-pulse latency of the next pulse cycle will be automatically shortened. Conversely, if the auto-activation signal does not appear during the pre-pulse latency of two consecutive pulse cycles, the pre-pulse latency of the next pulse cycle will be automatically extended.
[0008] Furthermore, the present invention can also automatically reduce the pulse amount of the next pulse cycle if no self-control activation signal appears in a pulse cycle. If no self-control activation signal appears in the next pulse cycle, the pulse amount of the next pulse cycle is further reduced until the self-control activation signal appears, and after the self-control activation signal appears, the pulse infusion is performed in advance and the pulse amount is restored to the initial pulse amount.
[0009] Furthermore, the present invention also includes control units such as a pre-pulse latency timer, a post-pulse lock timer, and a self-controlled activation signal counter.
[0010] The pre-pulse latent timer and post-pulse lock timer are used to control the length of these two time periods and serve as a control unit for the pulse interval; the self-controlled activation signal counter is used to record the number of self-controlled activation signals within the pulse cycle and the specific pulse cycle in which the activation signal is generated, that is, whether the self-controlled activation signal is in the pre-pulse latent period or the post-pulse lock period. If the self-controlled activation signal appears in the pre-pulse latent period, pulse infusion is performed in advance and is used to control the changes in the pre-pulse latent time and pulse amount.
[0011] Furthermore, the present invention also includes a network system, which includes a central monitoring server, a display screen, a signal receiving device connected to the central monitoring server for communication, and a signal transmitting device provided on the pump body, wherein the signal transmitting device is used to transmit data to the central monitoring server.
[0012] The central monitoring server may be a server control platform currently used in hospitals or workstations, and is connected to the infusion pump via wired or wireless communication.
[0013] Preferably, the signal transmitting device and the signal receiving device are selected from but not limited to any one or more combinations of communication modes including Wi-Fi, Bluetooth, and RFID.
[0014] The present invention also provides another technical solution: a control method of an intelligent infusion pump with a variable pulse interval, the steps are as follows: Step S1, perform pulse infusion, start the post-pulse lock timer and the automatic activation signal counter, and execute step S2; Step S2, determine whether the post-pulse lock timer is completed; if yes, go to step S4; if no, go to step S3; Step S3, determine whether there is an automatic control activation signal; if yes, execute step S0; if no, continue to execute step S2; Step S0, the automatic activation signal counter records an invalid activation signal once, and executes step S2; Step S4, start the pre-pulse latency timer, and execute step S5; Step S5, determining whether the pre-pulse latency timer is completed; if yes, executing step S1; if no, executing step S6; Step S6, determine whether there is an automatic control activation signal; if yes, proceed to step S7; if no, continue to step S5; Step S7, the self-controlled activation signal counter records a valid activation signal, ends the pre-pulse latency timer and executes step S1.
[0015] Compared with the prior art, the present invention has the following advantages and effects: the pulse cycle of the existing pulse pump includes pulse infusion, post-pulse locking time, self-controllable time, and pre-pulse locking time in sequence. When the self-control signal is activated during the middle self-controllable time, effective self-controllable infusion can be performed to meet the demand, and when the demand occurs during the pre-pulse locking time, it can only wait for the arrival of the next pulse. In particular, when there is no self-controllable infusion in the middle but pain occurs during the pre-pulse locking time, infusion cannot be performed, which will increase the pain waiting time and cannot meet the demand. The pulse cycle of the intelligent infusion pump with variable pulse interval of the present invention includes pulse infusion, post-pulse locking time, and pre-pulse latent time in sequence. Through the variable pulse interval technology, pulse infusion can be performed in advance when analgesia is required, which can provide better use effect. BRIEF DESCRIPTION OF THE DRAWINGS
[0016] Figure 1 It is a flow chart of a control method of an intelligent infusion pump with a variable pulse interval in an embodiment of the present invention. DETAILED DESCRIPTION
[0017] The technical solutions in the embodiments of the present invention are clearly and completely described below. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in the field without making creative work are within the scope of protection of the present invention.
[0018] The present embodiment provides an intelligent infusion pump with a variable pulse interval, including a pump body, a liquid storage device, an infusion pipeline, and a control system; the control system can set infusion parameters such as the total infusion volume, the first volume, the first volume lock time, the pulse volume, the pulse interval, the post-pulse lock time, the pre-pulse latent time, the limit volume, and the continuous infusion volume.
[0019] After setting the parameters, the first volume infusion and the first volume lock time will be entered. After the first volume lock time is over, the first pulse infusion will be automatically entered. After the first pulse infusion is completed, the post-pulse lock time will be entered. After the post-pulse lock time is over, the pre-pulse latent time will be entered. After the pre-pulse latent time is over, the next pulse infusion will be carried out, that is: post-pulse lock time + pre-pulse latent time = pulse interval time. A pulse cycle is from the appearance of a pulse to the arrival of the next pulse. If the self-control activation signal appears during the post-pulse lock time, it is invalid self-control; if the self-control signal is activated during the pre-pulse latent time, the pulse infusion will be carried out in advance.
[0020] In this embodiment, the control system can also set the change size, upper limit and lower limit of each pre-pulse latency. The conditions for setting the pre-pulse latency to automatically increase and decrease are: pulse advance occurs in N consecutive pulse cycles and pulse advance does not occur in M consecutive pulse cycles.
[0021] For example, if the auto-activation signal appears during the pre-pulse latency of two consecutive pulse cycles, resulting in two consecutive premature pulse infusions, the pre-pulse latency of the next pulse cycle will be automatically shortened. Conversely, if the auto-activation signal does not appear during the pre-pulse latency of two consecutive pulse cycles, the pre-pulse latency of the next pulse cycle will be automatically extended.
[0022] Alternatively, if no automatic activation signal appears in a pulse cycle, the pulse amount of the next pulse cycle is automatically reduced. If no automatic activation signal appears in the next pulse cycle, the pulse amount of the next pulse cycle is further reduced until the automatic activation signal appears. After the automatic activation signal appears, the pulse infusion is performed in advance and the pulse amount is restored to the initial pulse amount.
[0023] In this embodiment, control units such as a pre-pulse latency timer, a post-pulse lock timer, and a self-controlled activation signal counter are also included.
[0024] The pre-pulse latency timer and the post-pulse lock timer are used to control the length of these two time periods and serve as a control unit for the pulse interval; the automatic activation signal counter is used to record the number of automatic activation signals within the pulse cycle and the specific pulse cycle in which the activation signal is generated, that is, whether the automatic activation signal is in the pre-pulse latency period or the post-pulse lock period. If the automatic activation signal appears in the pre-pulse latency period, the pulse infusion is carried out in advance and it is used to control the changes in the pre-pulse latency time and pulse amount.
[0025] In this embodiment, a network system is also included, which includes a central monitoring server, a display screen, a signal receiving device connected to the central monitoring server for communication, and a signal transmitting device provided on the pump body, and the signal transmitting device is used to transmit data to the central monitoring server.
[0026] The central monitoring server may be a server control platform currently used in hospitals or workstations, and is connected to the infusion pump via wired or wireless communication.
[0027] The signal transmitting device and the signal receiving device are selected from but not limited to any one or more combinations of communication modes such as Wi-Fi, Bluetooth, and RFID.
[0028] In this embodiment, the control method of the intelligent infusion pump with variable pulse interval is as follows: Step S1, perform pulse infusion, start the post-pulse lock timer and the automatic activation signal counter, and execute step S2; Step S2, determine whether the post-pulse lock timer is completed; if yes, go to step S4; if no, go to step S3; Step S3, determine whether there is an automatic control activation signal; if yes, execute step S0; if no, continue to execute step S2; Step S0, the automatic activation signal counter records an invalid activation signal once, and executes step S2; Step S4, start the pre-pulse latency timer, and execute step S5; Step S5, determining whether the pre-pulse latency timer is completed; if yes, executing step S1; if no, executing step S6; Step S6, determine whether there is an automatic control activation signal; if yes, proceed to step S7; if no, continue to step S5; Step S7, the self-controlled activation signal counter records a valid activation signal, ends the pre-pulse latency timer and executes step S1.
[0029] The parameters of the intelligent infusion pump with variable pulse interval in Example 1 are set, and the total infusion amount is set to 150ml, the first amount is 8ml, the first amount lock time is 40 minutes, the pulse amount is 10ml, the lock time after the pulse is 15 minutes, the pre-pulse latent time is 25 minutes, the limit amount is 30ml / h, and the continuous infusion amount is 0ml / h. If the automatic activation signal appears in the pre-pulse latent time of two consecutive pulse cycles, resulting in two consecutive pulses being infused in advance, the pre-pulse latent time of the next pulse cycle is automatically shortened. On the contrary, if the automatic activation signal does not appear in the pre-pulse latent time of two consecutive pulse cycles, the pre-pulse latent time of the next pulse cycle is automatically extended. The change size of each pre-pulse latent time is set to ±5 minutes, and the upper and lower limits are 20 minutes and 40 minutes respectively.
[0030] The operation starts at 8:20, and the first amount of 8ml is infused, followed by a 40-minute first-volume lock time; the first pulse infusion of 10ml is performed at 9:00, followed by a 15-minute post-pulse lock time; then the pre-pulse latent time is entered, and the automatic activation signal appears at 9:35, and a 10ml pulse infusion is performed in advance and a 15-minute post-pulse lock time is entered; the pre-pulse latent time begins at 9:50, and the automatic activation signal appears at 10:10, and a 10ml pulse infusion is performed in advance again. Since the pulses in two consecutive cycles are infused in advance, the pre-pulse latent time in the next pulse cycle is automatically adjusted from 25 minutes to 20 minutes, and the pulse interval at this time is 35 minutes. Two pulse infusions occur at 10:45 and 11:20. Since no automatic activation signal appears in these two consecutive pulse cycles, the pre-pulse latent time of the next cycle is automatically extended by 5 minutes, that is, adjusted to 25 minutes.
[0031] The parameters of the intelligent infusion pump with variable pulse interval in Example 1 are set to 100 ml total infusion, 0 ml first volume, 60 minutes first volume lock time, 12 ml pulse volume, 15 minutes post-pulse lock time, 35 minutes pre-pulse latency, 30 ml / h limit volume, and 5 ml / h continuous infusion volume. If no automatic activation signal appears during the pre-pulse latency of a pulse cycle, the pulse volume of the next pulse cycle is automatically reduced by 2 ml each time, with a minimum of 5 ml. If the pulse is infused prematurely, the pulse volume is restored to 12 ml for infusion.
[0032] The operation started at 8:00, with the first infusion of 0 ml and the first volume lock time of 60 minutes; the first pulse infusion of 12 ml and the post-pulse lock time of 15 minutes were performed at 9:00; then the pre-pulse latent time was entered, and no automatic activation signal appeared. At 9:50, a pulse infusion of 10 ml was performed, and in the next pulse cycle, there was still no automatic activation signal. At 10:40, a pulse infusion of 8 ml was performed, and an automatic activation signal appeared at 11:10. During the pre-pulse latent time, the pulse infusion was performed in advance, and the pulse volume was restored to the initial 12 ml. There was no automatic activation signal in the next pulse cycle, and at 12:00, a pulse infusion of 10 ml was performed.
[0033] Although embodiments of the present invention have been shown and described, it will be apparent to those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and concepts of the present invention, and the scope of the present invention is defined by the appended claims and their equivalents.
Claims
1. An intelligent infusion pump with variable pulse interval, comprising a pump body, a liquid storage device, an infusion pipeline and a control system; characterized in that: The control system can set infusion parameters including total infusion volume, first volume, first volume lock time, pulse volume, pulse interval, post-pulse lock time, pre-pulse latency time, limit volume, and continuous infusion volume; After the pulse infusion is completed, the post-pulse lock time will begin. After the post-pulse lock time ends, the pre-pulse latent time will begin. After the pre-pulse latent time ends, the next pulse infusion will begin, that is: post-pulse lock time + pre-pulse latent time = pulse interval time; A pulse cycle is from the appearance of a pulse to the arrival of the next pulse. When the self-control activation signal appears within the post-pulse locking time, it is invalid self-control; when the self-control signal is activated within the pre-pulse latent time, the pulse infusion is performed in advance.
2. The intelligent infusion pump with variable pulse interval according to claim 1, characterized in that: The control system can also set the size, upper limit and lower limit of each change of the pre-pulse latency time; the conditions for setting the automatic increase and decrease of the pre-pulse latency time are: pulse advance occurs in N consecutive pulse cycles and pulse advance does not occur in M consecutive pulse cycles.
3. The intelligent infusion pump with variable pulse interval according to claim 2, characterized in that: When the self-controlled activation signal appears in the pre-pulse latency time of two consecutive pulse cycles, resulting in two consecutive premature pulse infusions, the pre-pulse latency time of the next pulse cycle is automatically shortened; When no self-control activation signal appears during the pre-pulse latency of two consecutive pulse cycles, the pre-pulse latency of the next pulse cycle is automatically extended.
4. The intelligent infusion pump with variable pulse interval according to claim 1 or 2, characterized in that: When there is no self-control activation signal in a pulse cycle, the pulse amount of the next pulse cycle is automatically reduced; When the self-control activation signal still does not appear in the next pulse cycle, the pulse amount of the next pulse cycle is further reduced until the self-control activation signal appears. After the self-control activation signal appears, the pulse infusion is performed in advance and the pulse amount is restored to the initial pulse amount.
5. The intelligent infusion pump with variable pulse interval according to claim 1, characterized in that: Also included are a pre-pulse latency timer, a post-pulse lockout timer, and a self-controlled activation signal counter.
6. The intelligent infusion pump with variable pulse interval according to claim 5, characterized in that: The pre-pulse latency timer and post-pulse lock timer are used to control the length of the pre-pulse latency time and the post-pulse lock time respectively, and serve as a control unit for the pulse interval; the self-controlled activation signal counter is used to record the number of self-controlled activation signals within the pulse cycle and the specific pulse cycle in which the activation signal is generated. The specific pulse cycle in which the activation signal is generated is the pre-pulse latency period or the post-pulse lock period. When the self-controlled activation signal appears in the pre-pulse latency period, pulse infusion is performed in advance and is used to control the changes in the pre-pulse latency time and pulse amount.
7. The intelligent infusion pump with variable pulse interval according to claim 1, characterized in that: It also includes a network system, which includes a central monitoring server, a display screen, a signal receiving device connected to the central monitoring server for communication, and a signal transmitting device arranged on the pump body, and the signal transmitting device is used to transmit data to the central monitoring server.
8. The intelligent infusion pump with variable pulse interval according to claim 7, characterized in that: The central monitoring server is a server control platform used in hospitals or workstations, and is connected to the infusion pump via wired or wireless communication.
9. A control method for an intelligent infusion pump with a variable pulse interval according to any one of claims 1 to 8, characterized in that the steps as follows: Step S1, perform pulse infusion, start the post-pulse lock timer and the automatic activation signal counter, and execute step S2; Step S2, determining whether the post-pulse lock timer is completed; If yes, proceed to step S4; No, proceed to step S3; Step S3, determining whether there is an automatic control activation signal; If yes, proceed to step S0; No, continue to step S2; Step S0, the automatic activation signal counter records an invalid activation signal once, and executes step S2; Step S4, start the pre-pulse latency timer, and execute step S5; Step S5, determining whether the pre-pulse latency timer is completed; if yes, executing step S1; No, go to step S6; Step S6, determining whether there is an automatic control activation signal; If yes, go to step S7; if no, go to step S5; Step S7, the self-controlled activation signal counter records a valid activation signal, ends the pre-pulse latency timer and executes step S1.
